NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea · Delayed Price · Currency is KRW 2,245.00
+230.00 (11.41%)
At close: Jan 29, 2026
NGeneBio Market Cap
NGeneBio has a market cap or net worth of 56.21 billion as of January 30, 2026. Its market cap has increased by 71.24% in one year.
Market Cap
56.21B
Enterprise Value
66.49B
Revenue
9.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,245.00
Market Cap Chart
Since December 10, 2020, NGeneBio's market cap has decreased from 313.33B to 56.21B, a decrease of -82.06%. That is a compound annual growth rate of -28.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 56.21B | 53.77% |
| Dec 30, 2025 | 36.56B | 12.79% |
| Dec 30, 2024 | 32.41B | -54.77% |
| Dec 28, 2023 | 71.66B | -38.23% |
| Dec 29, 2022 | 116.03B | -42.38% |
| Dec 30, 2021 | 201.38B | -46.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MOA Life Plus | 69.70B |
| Ark Solutions | 68.91B |
| SunBio,Inc. | 67.92B |
| EyeGene | 65.28B |
| J2KBIO | 48.94B |
| Aptamer Sciences | 48.91B |
| SCM Lifescience | 35.98B |
| Kainos Medicine | 35.56B |